Sorafenib tosylate (Nexavar)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Sorafenib tosylate (Nexavar), covering 2018-05-24 to 2018-05-24. Get the full timeline:
Most recent: Clinical Trial Update: Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck [Phase 1]